Zyclastin 4mg Injection 1s

Zyclastin 4mg Injection 1s is employed to manage high calcium levels in the blood, known as hypercalcemia, which can arise in cancer patients. Additionally, it's used in treating multiple myeloma (a cancer related to bone marrow cells) and specific bone metastases (when cancer spreads to the bone).

It belongs to a group of drugs known as bisphosphonates. It reduces bone breakdown, boosts bone density (thickness), and lowers calcium release from bones into the bloodstream.

It is additionally employed for treating Paget's disease of the bone in both men and women. It's also used for osteoporosis treatment in men and postmenopausal women, aiming to reduce fracture risks, particularly in patients who recently experienced a hip fracture.

Patients prescribed it should adhere to their healthcare provider's recommendations regarding dosage and duration of treatment.

It is crucial to report any persistent symptoms or adverse effects promptly.